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Abstract
Presently there is no clear evidence for the ability of mature osteogenic lineage cells to dedifferentiate. In order to identify
and trace mature osteogenic lineage cells, we have utilized transgenic mouse models in which the dentin matrix protein 1
(Dmp1) promoter drives expression of GFP (active marker) or Cre recombinase (historic label) in preosteocytes/osteocytes.
In long bone chip outgrowth cultures, in which cells on the bone surface were enzymatically removed, cells with previous
activity of the Dmp1 promoter migrated onto plastic and down-regulated Dmp1-GFP expression. Dmp1Cre-labeled cells
from these cultures had the potential to re-differentiate into the osteogenic lineage, while the negative population showed
evidence of adipogenesis. We observed numerous Dmp1Cre-labeled osteoblasts on the surface of bone chips following
their in vivo transplantation. Our data indicate that cells embedded in bone matrix are motile, and once given access to the
extra bony milieu will migrate out of their lacunae. This population of cells is phenotypically and functionally heterogeneous
in vitro. Once the preosteocytes/osteocytes leave lacunae, they can dedifferentiate, potentially providing an additional
source of functional osteoblasts.
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Introduction
Osteocytes, the cells residing within the bone matrix, represent
more than 95% of the cellular component of adult bone tissue.
They communicate with other osteocytes, and osteoblast lineage
cells at the endosteal surface through the lacuna-canalicular
system. Formation of this complex network is ideally suited for
mechanosensation and integration of local and systemic signals.
Osteocytes originate from mesenchymal stem cells (MSCs)
through osteoblast lineage differentiation, with only 10–20% of
osteoblasts differentiating into osteocytes [1]. Although there are
still many unanswered questions about the differentiation process,
our knowledge of the transition from osteoblast to osteocyte has
expanded dramatically due to the identification of several
osteocyte specific markers such as dentin matrix protein 1
(Dmp1) [2,3,4,5], matrix extracellular phosphoglycoprotein
(MEPE), phosphate regulating endopeptidase homolog (PHEX)
and sclerostin (Sost) [6,7,8]. Dmp1 is an extracellular matrix-
associated phosphoprotein, with expression restricted to mineral-
ized tissues in mouse, rat and chicken [2,9]. Based on the
expression of Dmp1 in osteocytes, several investigators have
utilized different lengths of the Dmp1 promoter to direct Cre
recombination to this cell type [10,11,12,13].
Knowledge of the molecular signature of osteocytes has allowed
a more direct analysis of the molecular and cellular biology of
these cells. Insight into the process of osteoblast to osteocyte
transition has been gained using transgenic mouse lines in which
GFP variants are expressed in osteoblasts and/or osteocytes,
allowing visual identification of cells at specific differentiation
stages [5,14]. In addition, the Cre/loxP system is a valuable
technology to evaluate gene deletion or to target gene expression
to specific tissues at a particular stage of differentiation. By
combining cell-type specific Cre activity with a Cre-activated
reporter gene, lineage tracing studies can be performed. Although
the combinatorial approach of using visual markers for transgene
expression and Cre/loxP recombination system has addressed
some of the unresolved questions about the differentiation process,
many aspects are still unknown.
Mature osteoblasts are one of the major cell types responsible
for achieving a balance between bone resorption and the
formation of new bone. Bone formation can be augmented by
increased induction of mesenchymal progenitor cells into osteo-
progenitors and their subsequent differentiation into osteoid-
secreting osteoblasts. In addition, activation of quiescent bone
lining cells into matrix-producing osteoblasts has been document-
ed as a mechanism for increasing the bone forming cell population
[15]. The lineage can also add to its overall activity by inhibition of
apoptosis of osteoblasts and osteocytes. These processes are well
documented by both in vitro and in vivo studies [16,17,18,19,20,21].
However, the potential of the osteocyte, the most abundant cell in
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bone, to function as a bone-forming cell through its ability to
dedifferentiate, has not been recognized.
Here, we evaluated the ability of Dmp1-expressing preosteo-
cytes/osteocytes to dedifferentiate in vitro and in vivo. We have
utilized transgenic mice in which the Dmp1 promoter drives GFP
expression as a visual marker of the current stage of differentiation
(Dmp1-GFP), or drives Cre recombinase in order to activate an
historical reporter (Ai9) in osteocytes and their progeny
(Dmp1Cre/Ai9). We have used a primary culture model in which
long bone chips are enzymatically stripped of surface cells, then
cultured, allowing outgrowth of cells. A similar model has been
utilized to show the presence of MSCs within bone chips [22].
Here, we report that Dmp1Cre/Ai9 positive cells embedded in
bone, can move out of their lacunae, and develop an osteoblastic
phenotype in vitro and in vivo.
Materials and Methods
Ethics Statement
All animal protocols were approved by the Animal Care
Committee of the University of Connecticut Health Center under
protocol numbers 2009-584 and 100490-0815.
Mice
Generation and genotyping of the 8 kb Dmp1 promoter-driven
GFP (Dmp1-GFP) mice was described previously [5]. 10 kb
Dmp1Cre mice were obtained from Dr. Feng [10], and bred with
the Ai9 reporter mouse (stock # 007905, Jackson Labs, Bar
Harbor, ME) to generate Dmp1Cre/Ai9 mice. The Ai9 mice
harbor a targeted mutation of the Gt(ROSA)26Sor locus with a
loxP-flanked STOP cassette preventing transcription of a CAG
promoter-driven red fluorescent protein variant (tdTomato) [23].
Immunodeficient NOD/SCID/IL-2 receptor common gamma
chain deficient mice (NOD/SCID/IL-2r null) were previously
described [24].
Bone outgrowth cell cultures (BOCs)
Femurs and tibias from 2-3-month-old mice were dissected and
cleaned of adherent muscle and periosteum. The epiphyseal
growth plates were removed and the bone marrow was flushed.
The cortical bone was minced into chips, washed several times
with PBS and digested in 0.25% trypsin-EDTA (Gibco, Life
Technologies, Carlsbad, CA) supplemented with 0.2% collagenase
A (Roche, Indianapolis, IN), for 45 minutes at 37uC with 300 rpm
shaking. Chips were then washed thoroughly with PBS then either
fixed for histology or plated at a density of bone chips from 2–3
mice per 100 mm dish in 6 ml of minimum essential media alpha
(aMEM) containing 100 U/ml penicillin, 100 mg/ml streptomycin
(Gibco) and 10% fetal calf serum (FCS, HyClone, Logan, UT)
(basal culture conditions). On day 4, additional medium was
added (4 ml), followed by a complete change on day 7. Chips were
cultured for 10 days to allow the cells within the bone migrate out
and adhere onto the culture dish.
Histological analysis
Bone samples were fixed in 4% paraformaldehyde/PBS (pH
7.4) at 4uC for 3 days, decalcified in 14% EDTA for up to 7 days,
placed in 30% sucrose overnight and embedded in cryomedium
(Thermo Fisher Scientific, Waltham, MA). Sections of 5 mm were
obtained using a Leica cryostat (Wetzler, Germany) and tape
transfer system (Section-lab, Hiroshima, Japan). Images were
obtained using appropriate filters optimized for green fluorescent
protein (GFP) variants (Chroma Technology, Bellows Falls, VT)
using an Observer Z1 microscope (Carl Zeiss, Thornwood, NY).
Images were obtained in gray scale, pseudocolored and composite
images were assembled. To obtain a full-size image of bone chip
implants, images were scanned at high power and then stitched
into a composite.
Flow Cytometry
FACS phenotype analysis and cell sorting of Dmp1Cre/Ai9
cells were performed using BD FACSAria II or LSR II (BD
Biosciences, San Jose, CA) equipped with five lasers and 18
fluorescence detectors. Following 10 days in culture, BOCs were
digested with 0.25% trypsin and single-cell suspensions were
prepared in staining medium (2% FCS in PBS). Sorting gates were
defined using cells from non-transgenic mice. Dmp1Cre/Ai9+ and
Dmp1Cre/Ai92 populations were sorted in aMEM/20% FCS
collection buffer kept at 4uC. For characterization of the cell
surface phenotype, we used antibodies purchased from e-
Biosciences (San Diego, CA) unless otherwise stated. The following
antibodies were used: APC-anti-CD45 (clone 30-F11), biotin-anti-
CD140aPDGFRa (clone APA5), FITC-anti-CD90.2/Thy-1.2
(clone 30-H12); FITC-anti-CD106 (clone 429); biotin-anti-
CD105 (clone MJ7/18), efluor450 anti-CD31 (clone 390); Pacific
blue anti-Sca-1 (clone D7) (BioLegend, San Diego, CA). Stainings
with biotinylated antibodies underwent a secondary incubation
with streptavidin coupled to efluor780. All data were analyzed
using BD CellQuest or Diva software.
In vitro studies
Differentiation assays. After one week of basal culture
conditions, the BOC were cultured in aMEM/10% FCS, 50 mg/
ml ascorbic acid, 8 mM b-glycerol phosphate for 2 weeks to
induce osteogenic differentiation. To evaluate osteogenic differ-
entiation in Dmp1Cre/Ai9+ and Dmp1Cre/Ai92 sorted popula-
tions, cells were seeded as 20 ml spots containing 56104 cells [25].
After 2 h, aMEM/10% FCS was added, and 24 h later cells were
placed under osteogenic induction. For adipogenic differentiation,
cells were plated at a density of 1.36104 cells/cm2 in 24-well plates
and induced using aMEM/10% FCS, 1 mM insulin, 0.5 mM
rosiglitazone for 9 days.
Histochemical analysis of cell cultures. Osteogenic and
adipogenic phenotypes were determined using modified von Kossa
silver nitrate staining, and Oil Red O staining, respectively
[14,26]. Images were acquired using a flat bed scanner and
processed with Adobe Photoshop.
Detection of epifluorescence. GFP expression in cell
cultures was visualized using an Olympus IX50 inverted system
microscope equipped with IX-FLA inverted reflected light
fluorescence (Olympus America Inc., Melville, NY). A specific
excitation wavelength was obtained using filters for GFPtopaz
(excitation: D500/20, emission: D550/40) and RFP (excitation:
560/40, emission: 630/75). Images were recorded with a SPOT-
camera (Diagnostic Instruments Inc., Sterling Heights, MI).
Gene expression analysis
Cultures or bone chips were homogenized in Trizol solution
using a polytron (Ika) for approximately 40 seconds. RNA was
extracted and converted into cDNA utilizing Improm-IITM
Reverse Transcription System (Promega). Real-time PCR was
performed using TaqManH Gene Expression Assays specific for
Gapdh (Mm99999915_g1), dentin matrix protein 1 (Dmp1,
Mm00803833--_g1), bone sialoprotein (Bsp, Mm00492555_m1),
Sost (Mm00470479_m1), adipsin (Mm00442664_m1) and adipo-
nectin (Mm00456425_m1). Data obtained were normalized to
Gapdh expression levels. Differences in expression between
selected groups were compared using Student’s t-tests.
Osteocyte Dedifferentiation
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Time lapse imaging
BOC cultures were examined with a Zeiss Observer.Z1
microscope (Carl Zeiss) equipped with an imaging chamber
maintaining 37uC and 6% CO2 in a humidified atmosphere. Cells
were imaged beginning 72 hours after initiation of the culture, for
the successive 48 hours, and images were taken every 40 minutes
using an AxioCam color digital camera controlled by a user-
defined computation program [27]. Fluorescent expression of
Dmp1Cre/Ai9 in cultures was examined using a TRITC red filter
(Chroma). Final.zvi files were converted into tiff files using
AxioVision digital image processing software (Carl Zeiss).
Subcutaneous implantation of bone chips
Bone chips from two Dmp1Cre/Ai9 mice were prepared as
described. Following enzymatic digestion and washes they were
mixed with 200 ml 3 mg/ml collagen type I (BD Biosciences)
prepared according to the manufacturer’s instructions [28].
Immunodeficient NOD/SCID/ILr-2 deficient mice (3–4 month
old) were anesthetized with ketamine/xylazine (135 mg/kg and
15 mg/kg) and the bone chips/gel implant placed subcutaneously
under the left and right scapula. After surgery, 0.08 mg/kg
buprenorphine hydrochloride was administered subcutaneously
for analgesia. Implants were performed as three separate
experiments, with one mouse sacrificed after 5 days (total n = 3)
and two after 28 days (total n = 6) in each experiment. Following x-
ray imaging, implants and surrounding tissues were collected and
processed for histological analysis.
Results
Expression patterns of the Dmp1 reporter genes
In order to determine whether the Dmp1 reporters used for this
study were osteocyte-specific, we first examined their distribution
histologically. As described previously, Dmp1-GFP mice demon-
strated restricted expression of GFP to cells embedded in the bone
[5,29]. Histological analysis of femur and calvaria from 2–3
month-old transgenic mice showed GFP signal in cortical and
trabecular osteocytes (Fig. 1A–C). Sections of long bone trabeculae
from non-transgenic mice were used to demonstrate the
background fluorescence (Fig. 1D).
Dmp1Cre transgenic mice were crossed with the Ai9 reporter
transgenic line to generate Dmp1Cre/Ai9 mice. In these
compound mice, the expression of Cre is activated under the
control of the 10kb Dmp1 promoter. Cre activity activates
expression of the tdTomato visual reporter (Ai9), allowing lineage
tracing of Dmp1-expressing cells and their progeny. Histological
examination shows that Cre-directed recombination was detected
in cortical osteocytes (indicated by arrowheads) and on some
endocortical osteoblasts (indicated by arrows) (Fig. 1A’–B’). Similar
expression of tdTomato was observed in the majority of osteocytes
and some osteoblasts in trabecular bone (Fig. 1C’). The majority of
skeletal muscle fibers were tdTomato positive indicating the
activity of the promoter in the skeletal muscle or in the muscle
progenitor cells at some point in the animal’s lifetime (Fig. 1B’).
Dmp1Cre-labeled bone-embedded cells dedifferentiate
in vitro
To evaluate the ability of preosteocytes/osteocytes to dediffer-
entiate in vitro, we established a bone outgrowth cell culture model.
Histology of bone chips before and after the enzymatic digestion
step confirmed that osteoblasts and bone lining cells were
completely removed while osteocytes remained within the bone
matrix (Fig. S1). After 3–5 days of culture, cells started to appear
around the bone chips attached to the tissue culture plate, and
migrate away from chips.
In cultures from Dmp1-GFP mice, GFP expression was
restricted to osteocytes within the bone chips, while few or no
cells expressing GFP were observed in BOCs by epifluorescence
(Fig. 2A–B), or by immunofluorescent staining for GFP (data not
shown). These data indicate that at this point in culture, BOC do
not show detectable activity of the osteocyte-specific Dmp1
promoter. To determine whether the BOCs are the progeny of
osteocytes, cultures were performed using bones from Dmp1Cre/
Ai9 mice. In contrast to the absence of Dmp1-GFP expression
(Fig. 2A–B), BOCs from Dmp1Cre/Ai9 mice showed tdTomato
fluorescence in a numerous cells surrounding bone chips (Fig. 2C–
D). As tdTomato is expressed only in cells in which Cre was once
active, and Dmp1 promoter activity is absent in the BOCs, these
data confirm that tdTomato expression is due to the historical
activation of the Ai9 transgene by Dmp1Cre. To confirm that
Dmp1Cre/Ai9+ BOCs were derived from Dmp1Cre/Ai9+ bone
embedded cells, we performed time lapse imaging. Bone chips
derived from Dmp1Cre/Ai9 mice were visualized for 48 hours,
starting at day three of culture. We observed motile Dmp1Cre/
Ai9+ cells migrate towards the edge of bone chips, then onto the
surface of the culture dish, moving away from the bone chip in the
following hours (Fig. 3, Movie S1).
Phenotypical characterization of Dmp1Cre/Ai9+ cells
Previous work by Zhu et al. indicated that cells derived from
bone chips are mesenchymal progenitors capable of multi-lineage
differentiation [22]. To investigate whether the Dmp1Cre/Ai9+
BOCs showed characteristics of mesenchymal progenitor cells, we
analyzed the cell surface phenotype by flow cytometry. FACS
analysis indicated that the Dmp1Cre-activated transgene is present
in 18.662.7% (mean6SEM, n= 8) of cells (Fig. 4A and Fig. S2B).
We evaluated the expression of Dmp1Cre/Ai9+ cells for the
presence of CD45, a pan hematopoietic marker. Over 95% of
Dmp1Cre/Ai9+ cells were CD452 (96.161.6%), while
85.364.1% of the Dmp1Cre/Ai92 population was CD45+ (Fig.
4B). We also analyzed the CD452 compartment of Dmp1Cre/
Ai9+ and Dmp1Cre/Ai92 populations for the presence of
mesenchymal and endothelial markers. BOCs that are
Dmp1Cre/Ai9+/CD452 were negative for the endothelial marker
CD31 (Fig. 4C) as well as for mesenchymal markers CD106,
CD90 and CD140a/PDGFRa (data not shown). We also observed
expression of CD105 on 42.863.6%, while Sca1 was expressed in
a small population of Dmp1Cre/Ai9+/CD452 cells (9.962.2%)
(Figure 4C). Our data suggest that cells derived from bone
represent a heterogeneous population with only a small proportion
of them expressing markers associated with mesenchymal stem/
progenitor cells.
Differentiation potential of Dmp1Cre/Ai9+ BOCs in vitro
To test the extent of dedifferentiation and mesenchymal lineage
differentiation potential of cells from BOC cultures, we sorted
Dmp1Cre/Ai9+ and Dmp1Cre/Ai92 populations (Fig S2A–D).
Gene expression analysis of cells immediately post sorting
indicated that Dmp1Cre/Ai9+ and Dmp1Cre/Ai92 populations
both showed detectable Dmp1 expression, although levels were
consistently lower than in digested bone chips which are enriched
for mature osteocytes (Fig. S2E). In addition, the marker of mature
osteocytes, Sost, was not expressed in Dmp1Cre/Ai9+ and
Dmp1Cre/Ai92 cells (Fig. S2F). To evaluate their in vitro
differentiation potential, sorted BOCs were grown under osteo-
genic and adipogenic conditions. After 9 days of osteogenic
induction, Dmp1Cre/Ai9+ cells formed mineralized matrix
Osteocyte Dedifferentiation
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indicated by von Kossa staining while Dmp1Cre/Ai92 cells did
not exhibit that potential (Fig. 5A–B). The mature osteoblast/
osteocyte phenotype of cells derived from the Dmp1Cre/Ai9+
population was confirmed by induction of Bsp and Dmp1
expression (Fig. 5C). To substantiate these results, we established
primary BOC cultures from Dmp1Cre/Ai9/Dmp1-GFP trans-
genic mice. After one week in culture, GFP fluorescence was
restricted to osteocytes within the bone chips, while tdTomato was
evident both in cells embedded in the bone and in BOCs (Fig. S3).
After 6 days of osteogenic induction, a few Dmp1Cre/Ai9+ cells
became Dmp1-GFP+ and by 14 days a higher proportion of
Dmp1Cre/Ai9+ cells coexpressed Dmp1-GFP+ and formed
mineralized nodules (Fig. S3). We also tested the ability of sorted
cells to undergo adipogenesis. Adipocytes formed in the
Dmp1Cre/Ai92 cultures, but not the Dmp1Cre/Ai9+ cultures
(Fig. 6A–C).
Figure 1. Histology of Dmp1-GFP and Dmp1Cre/Ai9 bones. Detection of GFP expression in Dmp1-GFP derived histological sections (A–D). A
specific GFP signal was localized in osteocytes (arrowheads) of cortical bone in calvaria (A) and femur (B) and in trabeculae (C). Detection of tdTomato
expression in histological sections derived from Dmp1Cre/Ai9 transgenic mice (A’–D’). Cre-directed recombination was detected in osteocytes
(arrowheads) and in the osteoblast layer (arrows) of cortical bone from calvaria (A’) and femur (B’) and trabecular bone (C’). tdTomato expression was
also present in skeletal muscle (B’). Sections derived from GFP negative (D) and Dmp1Cre negative (D’) mice served as controls. Images were taken at
10X magnification and are representative of histology performed on 6 mice of each genotype. BM, bone marrow; LB, long bone; Ob’s, osteoblasts;
Oc’s, osteocytes.
doi:10.1371/journal.pone.0075204.g001
Figure 2. BOC are labeled by Dmp1Cre/Ai9 but do not express Dmp1-GFP. Primary bone chip outgrowth cell (BOC) cultures were obtained
by enzymatic digestion of long bones derived from Dmp1-GFP (A–B) and Dmp1Cre/Ai9 transgenic mice (C–D). After 3–5 days of culture, cells started
to crawl out of the chips (B, D, F). Dmp1-GFP expressing osteocytes can be observed within the bone chips while no GFP expression was observed in
BOC by epifluorescence (A). BOC from Dmp1Cre/Ai9 chips showed tdTomato fluorescence in a small proportion of cells (C). None of the outgrowth
cells derived from Dmp1Cre negative/Ai9 bone chips express Dmp1Cre/Ai9 (E). Upper panel, epifluorescence; lower panel, phase contrast imaging.
Images were taken at 10X magnification and are representative of at least 5 independent cultures.
doi:10.1371/journal.pone.0075204.g002
Osteocyte Dedifferentiation
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Dmp1Cre/Ai9+ cells can dedifferentiate in vivo
To test whether the Dmp1Cre/Ai9+ preosteocyte/osteocytes
are able to generate osteoblasts in vivo we traced Dmp1Cre/Ai9+
cells in a subcutaneous implantation model. Bone chips derived
from Dmp1Cre/Ai9 mice were enzymatically digested to removed
bone surface cells, mixed with collagen gel, and implanted
subcutaneously in immunodeficient mice, as shown by x-ray
(Fig. 7A). Five days after implantation, tdTomato expression was
still restricted to cells embedded within bone (Fig. 7B), as we
observed immediately following enzymatic digestion (Fig. S1).
Four weeks later, numerous Dmp1Cre/Ai9+ osteoblasts were
observed on bone chip surfaces. These data indicate that
preosteocytes/osteocytes can migrate out of bone and onto bone
surfaces, dedifferentiating to osteoblasts. These data provide an in
vivo correlate to our in vitro data.
Discussion
Cell dedifferentiation has been observed in a variety of
biological phenomena, such as cancer, organ regeneration, and
stem cell renewal, but it has been difficult to study due to a lack of
traceable experimental systems. In some tissues, cells that have
already begun to specialize can revert or "dedifferentiate" and
assume stem cell properties, including the ability to self-renew.
Dedifferentiation of specialized cells could provide a "reservoir" of
cells that may act as an additional resource that can be utilized in
extreme conditions such as injury repair that require massive
lineage activation [30,31]. Extensive evidence of dedifferentiation
exists in amphibians such as axolotls, where all tissue types,
including muscle, dermis, spinal cord, and cartilage regrow during
tail regeneration. Regeneration potential in mammals is much
more limited, but digit tips in mice and humans can regenerate.
Lineage tracing in mice after digit tip amputation indicated that
tissues in the regenerated digit including the dermis, bone, tendon
and vasculature were derived from local, lineage-restricted
Figure 3. Time lapse imaging of Dmp1Cre/Ai9 derived bone chips. Bone chips were imaged every 40 minutes starting at day three of culture.
The movement of Dmp1Cre+/Ai9 cells within the bone chips and their expulsion onto the culture plate was observed (moving cell is indicated by the
arrow). Representative images spanning a 14 h 20 minute period from the time points indicated are shown. Imaging was performed on three
independent cultures.
doi:10.1371/journal.pone.0075204.g003
Osteocyte Dedifferentiation
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progenitors, rather than a pluripotent stem cell or circulating
population [32]. The Cre transgenes used to label cells in this
study were not progenitor-specific, so a role for cellular
dedifferentiation in the provision of lineage-restricted progenitors
in this process cannot be ruled out.
Dedifferentiation of mammalian cells has been demonstrated in
vitro. Ectopic expression of Msx1 in C2C12 myotubes down-
regulated the nuclear muscle proteins MyoD and myogenin and
some myotubes cleave to produce smaller myotubes or prolifer-
ating, mononucleated cells [33]. Following these dedifferentiation
steps, clonal populations of the myotube-derived mononucleated
cells can be induced to re-differentiate into cells expressing
chondrogenic, adipogenic, myogenic, and osteogenic markers,
suggesting that terminally differentiated myotubes can dedifferen-
tiate into multipotent progenitors when stimulated with the
appropriate signals [33]. Mature adipocytes are also capable of
in vitro dedifferentiation using a method known as ceiling culture
[34]. The fibroblastic cell population generated, known as DFAT
cells, can re-differentiate to multiple lineages including adipocytes,
osteoblasts and chondrocytes in vitro, and reconstitute adipose
tissue, including vascular elements, in vivo [35,36]. Human DFAT
cells have also been reported to show other MSC-like properties
including support of hematopoiesis [37]. It is not clear, however,
whether this process can occur in vivo. Transdifferentiation of
human MSC-derived osteoblasts, chondrocytes and adipocytes to
alternative lineages has also been demonstrated after replating of
differentiated cultures in vitro, although in most of these cultures
only a subset of the replated cells would have reached terminal
differentiation stages [38].
Presently, there is no evidence that osteocytes, which are
considered terminally differentiated cells, are capable of dediffer-
entiation. Dedifferentiation of preosteocytes/osteocytes could
provide an unappreciated source of osteoblasts capable of
proliferation, differentiation and bone formation when bone is
under extreme stress. In our study, we have presented evidence
demonstrating the ability of preosteocytes/osteocytes to undergo
dedifferentiation in vitro and in vivo. This process generated cells
that could re-differentiate into bone matrix-producing osteoblasts.
We have utilized transgenic mice in which the Dmp1 promoter
drives the expression of Cre recombinase [10]. One limitation of
this model was the presence of Cre recombinase activity in
osteoblasts on the bone surface. However, following enzymatic
digestion of the bone chips we were able to remove all cells,
including osteoblasts, from the bone surface and proceed to
Figure 4. Cell surface marker expression in DmpCre/Ai9+ and DmpCre/Ai92 populations of BOC cultures. Primary BOC isolated from
Dmp1Cre/Ai9 mice were grown for ten days before analysis. Nontransgenic cells were utilized as controls to set the gate for tdTomato+ population (A,
mean6SEM, n = 8). Expression of pan-hematopoietic marker CD45 was evaluated in the BOC population (B). Expression of CD105, Sca1, and
endothelial marker CD31 was evaluated in the CD452 BOC cells (C). Dot-plots from a representative experiment are shown. Percentages within gated
populations represent mean6SEM of four biological replicates. Lineage marker expression was analyzed on at least 104 gated cells. Gates were set in
accord to the non-stained sample (not shown).
doi:10.1371/journal.pone.0075204.g004
Osteocyte Dedifferentiation
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culture chips where all Dmp1Cre/Ai9+ cells were matrix-
embedded (Fig. S1). Time-lapse imaging confirmed the movement
of cells within the chips, and their subsequent ability to migrate out
of the bone and adhere to tissue culture plastic. Similar
experiments describing cell movement within live calvaria have
been reported [39,40]. Veno et al. have also shown the presence of
a rare Dmp1-GFP+ cell population on the surface of calvaria that
can become very motile, move and then embed within the matrix
[41].
Zhu et al. have described a similar protocol to the one used in
this study for culturing enzymatically-digested mouse long bone
chips in order to isolate MSCs rapidly and with minimal
contamination [22]. However, we postulated that the primary
culture was heterogeneous, and included a population of cells that
in their lifetime expressed the Dmp1 promoter. Our cultures
appear to produce cells more slowly than the previous report [22],
possibly due to the use of older animals. Our cultures also show
much more varied cell surface marker expression, with extensive
contamination of cells expressing hematopoietic cell markers.
While the enzymatic digestion removes bone surface cells, the
intracortical microvasculature and innervation is not eliminated,
providing a potential source of hematopoietic cells, as well as other
cell types such as MSCs. It is notable that Zhu et al. do not assess
the cell surface marker phenotype or perform differentiation assays
Figure 5. Osteogenic potential of BOCs. Following sorting, Dmp1Cre/Ai9+ and Dmp1Cre/Ai92 populations were cultured under basal conditions
overnight (indicated as day 0) before treatment with osteogenic medium. After 9 days of osteogenic induction, Dmp1Cre/Ai9+ cells underwent
mineralization (A). Osteogenic differentiation was confirmed by von Kossa staining (B) and real-time PCR analysis of Bsp and Dmp1 mRNA expression
(C). Real-time PCR results are presented as mean6SEM of data normalized to Gapdh expression and pooled from two biological replicates. * P,0.05
compared to Dmp1Cre/Ai9+ day 9 as determined by two-tailed Student’s t-test. Bsp, bone sialoprotein; Dmp1, dentin matrix protein 1; ND, not
detectable.
doi:10.1371/journal.pone.0075204.g005
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until cultures have been passaged three times. This allows
expansion of stem/progenitor cells, and dilution of hematopoietic
contaminants and preosteocyte/osteocyte-derived cells, which are
likely to have more limited proliferative potential. Characteriza-
tion of the Dmp1Cre/Ai9+ population indicated that they do not
express MSC markers such as CD106, CD90 or PDGFRa. In
addition to lacking Dmp1-GFP expression, they show loss of
mature osteocyte marker Sost, and greatly reduced endogenous
Dmp1 expression compared to bone chips. Observations of cells
after replating suggest they also have some proliferative capacity,
although this capacity was not directly tested in this study. These
cells were able to differentiate into mature osteoblasts and
following mineralization, activate the Dmp1-GFP reporter, but
their differentiation potential appears to be restricted to the
osteogenic lineage. However, one of the MSC markers examined,
CD105, was expressed in a high proportion of cells. Sorting cells
based on CD105 expression ex vivo produces a population of cells
enriched for MSC-like properties, and it is expressed uniformly in
MSC cultures, but its expression is not unique to MSCs [42,43].
Gene expression profiling of differentiating calvarial osteoblast
cultures has indicated that, while expression of MSC markers such
as Sca1, CD106 and CD90 are down-regulated in differentiated
osteoblasts, CD105 expression does not change, suggesting that in
the in vitro context it can be expressed in more mature osteoblast
Figure 6. Adipogenic potential of BOCs. Sorted Dmp1Cre/Ai9+ and Dmp1Cre/Ai92 cells were cultured under basal conditions for 3 days
(indicated as day 0), then treated with adipogenic medium. Unlike Dmp1Cre/Ai9+, Dmp1Cre/Ai92 cells showed evidence of adipogenesis (A).
Adipogenic differentiation was assessed by Oil Red O staining (B) and adiponectin and adipsin expression levels by real-time PCR analysis (C). Real-
time PCR results are presented as mean6SEM of data normalized to Gapdh expression and pooled from two biological replicates. * P,0.05
compared to Dmp1Cre/Ai9+ day 9 as determined by two-tailed Student’s t-test. Statistical analysis was only performed where expression was
detectable in both samples. ND, not detectable.
doi:10.1371/journal.pone.0075204.g006
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lineage cells [44]. Sca1, a widely used marker of mouse MSCs
[43,45], was expressed on a small proportion of CD452 cells in
both the Dmp1Cre/Ai9+ and Dmp1Cre/Ai92 fractions, suggest-
ing there may be a subset of immature mesenchymal progenitors
in the cultures. The Dmp1Cre/Ai92 population showed restricted
differentiation potential, showing some adipogenesis, but not
osteogenic differentiation, and heterogeneous cell surface marker
expression. These observations confirm the heterogeneity of the
cells that were mobilized from bone chips, and suggest that cells
that formerly demonstrated a preosteocyte/osteocyte-like pheno-
type do not undergo complete dedifferentiation to a multi-potent
cell type, but contribute to a mixed population with osteogenic
potential.
It is well established that in vitro culture of cells can alter their
phenotype, and plasticity [42,46]. We therefore sought to assess
the potential for osteocyte dedifferentiation in vivo. However, in vivo
lineage tracing studies in clinically relevant models such as fracture
healing were precluded by Dmp1Cre activity in osteoblasts. To
circumvent this, we implanted denuded bone chips derived from
Dmp1Cre/Ai9 mice subcutaneously into immunodeficient mice.
Following four weeks in vivo, numerous osteoblasts were observed
lining the bone surfaces. This observation indicates that the
Dmp1Cre/Ai9+ cells from the donor animal have the ability to
dedifferentiate in vivo. Future studies using more osteocyte-specific
labeling systems, such as the inducible Dmp1CreERT2 [13]
should be utilized in future to confirm these results.
In summary, we have shown that bone-embedded preosteo-
cytes/osteocytes have the ability to dedifferentiate into less mature
osteogenic cells. Given that preosteocytes/osteocytes are embed-
ded within mineralized tissue in vivo, dedifferentiation would likely
require the ability to sense and gain access to the extra-bony
milieu. Fracture, joint replacement, and placement of screws in the
bone for securing plates and rods all expose the inner bone to the
extra-bony space. We can only speculate that this exposure may
mobilize osteocytes to dedifferentiate and then re-differentiate,
allowing them to participate in the repair process. Methods of
labeling osteocytes more specifically are required to demonstrate
this experimentally. Understanding the mechanisms by which
mature osteogenic cells activate their dedifferentiation potential,
and how these programs are utilized during tissue repair could
provide powerful strategies for regenerative medicine.
Supporting Information
Figure S1 Histological analysis of Dmp1Cre/Ai9 derived bone
chips. Bones derived from Dmp1Cre/Ai9 mice were minced into
,1 mm chips. Histology of bone chips before (A) and after (B)
enzymatic digest to remove cells on the bone surface was
performed. Following digestion, osteoblasts (arrows) and lining
cells were completely removed while osteocytes (arrowheads)
remained within the bone matrix. Images were taken at 10X
magnification. BM, bone marrow; Ob’s, osteoblasts; Oc’s,
osteocytes.
(TIF)
Figure S2 Cell sorting of BOC cultures derived from
Dmp1Cre/Ai9 mice. BOC from Dmp1Cre/Ai9 mice were
cultured for before FACS sorting. Nontransgenic cells were
utilized as controls to preset the sorting gates (A). The proportion
of Dmp1Cre/Ai9+ and Dmp1Cre/Ai92 cells is indicated (B).
Reanalysis of the sorted population purity is shown for Dmp1Cre/
Ai92 (C) and Dmp1Cre/Ai9+ (D) cells. Data is representative of
five different sorting experiments. RNA from digested bone chips
(n = 2), and from 10 day Dmp1Cre/Ai9+ and Dmp1Cre/Ai92
cultured cells immediately post sorting (n = 3) was used to assess
expression of osteocyte marker genes Dmp1 (E) and Sost (F).
Expression levels are presented as mean6SEM and are normal-
ized to Gapdh expression. Changes in Dmp1 expression were not
statistically significant. ND, not detectable; SSC, side scatter.
(TIF)
Figure S3 Differentiation of Dmp1Cre/Ai9+ BOC into Dmp1-
GFP expressing mature osteoblast cells. Primary BOC cultures
Figure 7. Dmp1Cre/Ai9+ cells dedifferentiate in vivo. Digested bone chips derived from Dmp1Cre/Ai9 mice were mixed with collagen type I
and implanted subcutaneously in immunodeficient mice, as shown by the representative x-ray image (A, arrows). Five and twenty-eight days
following implantation, the distribution of tdTomato+ cells was determined by histology (B).
doi:10.1371/journal.pone.0075204.g007
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from Dmp1Cre/Ai9/Dmp1-GFP transgenic mice were cultured
under basal conditions for 7 days (indicated as day 0) before
treatment with osteogenic medium for 6 or 14 days. Osteogenic
differentiation was confirmed by dual expression of red-labeled
Dmp1Cre/Ai9 and green-labeled Dmp1-GFP cells in conjunction
with the formation of mineralized nodules. BF, brightfield.
(TIF)
Movie S1 Time lapse imaging of Dmp1Cre/Ai9 derived bone
chips. Bone chips were imaged every 40 minutes for 48 hours
starting at day three of culture. The movement of Dmp1Cre+/Ai9
cells within the bone chips and their expulsion onto the culture
plate was observed.
(mp4)
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